Editas Medicine, Inc.
EDIT
$2.82
$0.010.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 47.01M | 38.69M | 40.52M | 46.38M | 38.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.01M | 38.69M | 40.52M | 46.38M | 38.90M |
| Cost of Revenue | 84.96M | 80.96M | 89.95M | 111.16M | 139.02M |
| Gross Profit | -37.95M | -42.27M | -49.43M | -64.78M | -100.12M |
| SG&A Expenses | 45.51M | 46.76M | 49.90M | 54.90M | 60.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.47M | 127.72M | 139.86M | 166.06M | 199.70M |
| Operating Income | -83.46M | -89.03M | -99.34M | -119.68M | -160.80M |
| Income Before Tax | -73.95M | -108.95M | -160.06M | -199.84M | -236.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -73.95 | -108.95 | -160.06 | -199.84 | -236.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.95M | -108.95M | -160.06M | -199.84M | -236.86M |
| EBIT | -83.46M | -89.03M | -99.34M | -119.68M | -160.80M |
| EBITDA | -81.04M | -85.19M | -94.06M | -112.04M | -152.28M |
| EPS Basic | -0.74 | -1.22 | -1.88 | -2.38 | -2.85 |
| Normalized Basic EPS | -0.50 | -0.60 | -0.71 | -0.90 | -1.19 |
| EPS Diluted | -0.74 | -1.22 | -1.88 | -2.38 | -2.85 |
| Normalized Diluted EPS | -0.50 | -0.60 | -0.71 | -0.90 | -1.19 |
| Average Basic Shares Outstanding | 404.52M | 369.64M | 354.81M | 340.17M | 332.57M |
| Average Diluted Shares Outstanding | 404.52M | 369.64M | 354.81M | 340.17M | 332.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |